Success of long-lasting HIV drug hinges on pricing
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drug
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Patent for HIV drug rejected, paves way for entry of generics
The Indian Patent Office has rejected Viiv Healthcare's patent application for the HIV drug, dolutegravir, after nearly a ...
pharmaphorum2d
Gilead, MSD say HIV combo could be weekly, oral HIV drug
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
Medscape6d
HIV-Positive Donors Safe for Kidney Transplants
The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...
Mass. budget includes language expanding access to preventative HIV medications
The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.
BlackDoctor9h
Essential Tips When Caring For An HIV-Positive Child
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Truepill’s Sid Viswanathan Is Back With A New Pharmacy Startup Focused On HIV
Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...
SciDev3d
Success of long-lasting HIV drug hinges on pricing
See privacy policy. [LIMA, PERU] Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has proven highly effective in human trials, ...
Times West Virginian4dOpinion
Biden-Harris admin must act to ensure equitable access to HIV prevention drugs
The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...
FiercePharma7d
With Gilead coming fast, GSK bolsters case for long-acting HIV PrEP drug Apretude
With Gilead Sciences sprinting to a likely approval next year for its long-acting pre-exposure prophylaxis (PrEP) drug for HIV, the California company has a chance to one-up GSK. While the British ...